- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02448498
Strength Training Regimen for Normal Weight Diabetics (STRONG-D)
April 7, 2021 updated by: Latha Palaniappan, MD, MS, Stanford University
The Strength Training Regimen in Normal Weight Diabetics (STRONG-D) study will examine the effectiveness of different exercise regimen types in controlling diabetes for the normal weight type 2 diabetes population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the STRONG-D study, participants are randomly assigned to strength training, aerobic training or a combined strength and aerobic training group.
Participants in the exercise group will attend exercise sessions over the course of 9 months at the YMCA.
Participants will have opportunities to engage in other activities such as educational run-in visits that will allow for measurement of hemoglobin A1c and emphasize the importance of exercise in improving Type 2 diabetes.
Study Type
Interventional
Enrollment (Actual)
289
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Stanford
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Recent hemoglobin A1c result between 6.5%-13%
- Diagnosis of Type 2 Diabetes Mellitus
- BMI between 18.5 -25 kg/m2
- Blood pressure < 160/100
- Sedentary lifestyle
- Able and willing to enroll and meet requirements of the study
Exclusion Criteria:
- Age less than 30 years or greater than 75 years
- Type 1 diabetes or use of insulin pump
- Triglycerides >500 mg/dL
- Use of weight loss medication
- Bariatric surgery
- Consumes >14 alcoholic drinks per week
- Pregnancy
- Plans to be away for more than four weeks
- Medical conditions which would prevent long-term participation or which would contraindicate physical activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Strength Training Only
Participants in the strength-training only group will take part in a 9-month exercise intervention at a local exercise facility.
They will engage in strength training 3 days per week for approximately 60 minutes each exercise session.
|
|
|
Experimental: Aerobic Training Only
Participants in the aerobic training only group will take part in a 9-month exercise intervention at a local exercise facility.
They will engage in aerobic training over 3 -5 days per week to achieve the targeted dose of 12 kcal/kg per week at a training intensity between 50-80% VO2 max.
|
|
|
Experimental: Combination (Strength and Aerobic) Training
Participants in the combination (strength and aerobic training) group will take part in a 9-month exercise intervention at a local exercise facility.
They will engage aerobic training that will expend 10 kcal/kg/week in combination with strength-training, 3 days per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Hemoglobin A1c across study visits
Time Frame: Baseline, monthly (for 9 months), 9-Months
|
Baseline, monthly (for 9 months), 9-Months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in body composition across study visits, as measured using DEXA
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in waist circumference across study visits
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in blood pressure across study visits
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in body weight across study visits
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Changes in cardiorespiratory fitness, as measured by 6-minute walk test
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in muscle strength and endurance, as measured by Biodex strength testing
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in quality of life
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in Dietary Intake, as measured by Food Frequency Questionnaire
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Latha Palaniappan, MD, MS, Stanford School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Actual)
July 1, 2020
Study Completion (Actual)
July 1, 2020
Study Registration Dates
First Submitted
March 6, 2015
First Submitted That Met QC Criteria
May 14, 2015
First Posted (Estimate)
May 19, 2015
Study Record Updates
Last Update Posted (Actual)
April 12, 2021
Last Update Submitted That Met QC Criteria
April 7, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 32113
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.